Skip to main content
. 2017 Apr 10;13(6):4035–4038. doi: 10.3892/ol.2017.6015

Figure 2.

Figure 2.

Expression levels of MAPK/P53 and FASN mRNA in SH081 bone tumor cells treated with MAPK/P53 inhibitor. Asterisk indicates significant difference between groups (P<0.05). MAPK, mitogen-activated protein kinase; FASN, fatty acid synthase.